Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates

WASHINGTON (AP) — A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was roundly criticized Tuesday — a potentially major setback to psychedelic advocates who hope to win a landmark federal approval and bring the banned drugs into the medical...

Service dogs helped ease PTSD symptoms in US military veterans, researchers say

Specially trained service dogs helped ease PTSD symptoms in U.S. military veterans in a small study that the researchers hope will help expand options for service members. The U.S. Department of Veterans Affairs provides talk therapy and medications to veterans with post-traumatic...

US panel rejects first-ever bid to use MDMA as a PTSD treatment in a possible setback for psychedelic advocates

WASHINGTON (AP) — US panel rejects first-ever bid to use MDMA as a PTSD treatment in a possible setback for psychedelic advocates.

Psychedelic drug MDMA faces questions as FDA considers approval for PTSD

WASHINGTON (AP) — Federal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort by advocates to move psychedelic drugs into the medical mainstream. The Food and...

Testimony ends in a trial over New Hampshire's accountability for youth center abuse

BRENTWOOD, N.H. (AP) — Jurors who will decide whether to hold New Hampshire accountable for abuse at its youth detention center heard from the final witness in a landmark trial Wednesday: a psychiatrist who said the plaintiff has bipolar disorder, not post-traumatic stress disorder. ...